C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction

被引:0
作者
Annichino-Bizzacchi, JM
Saad, STO
Arruda, VR
Ramires, JAF
Siqueira, LH
Chiaparini, LC
Mansur, AP
机构
[1] UNICAMP, Hemoctr, FCM Campinas, Campinas, SP, Brazil
[2] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil
[3] FCM UNICAMP, Disciplina Cardiol, Campinas, SP, Brazil
来源
JOURNAL OF CARDIOVASCULAR RISK | 2000年 / 7卷 / 01期
关键词
myocardial infarction; hemochromatosis; C282Y mutation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Iron is suspected to play a role in the development of atherosclerosis and in the progression of the disease, and consequently in myocardial infarction. Authors of a recent study identified a mutation in HLA-H gene, C282Y, that is an excellent marker for hemochromatosis, which is the most common cause of iron overload. There is a high prevalence of carriers of heterozygous hemochromatosis, most of whom are asymptomatic even with abnormalities of iron metabolism. Objective To study C282Y mutation in the HLA-H gene of 173 survivors of myocardial infarction matched with 172 controls by age, race, and sex, and 119 patients upon diagnosis of acute myocardial infarction. Methods Identification of the mutation was performed by PCR amplification of the DNA fragment followed by RsaI digestion. Results The prevalence of heterozygotes for the mutated allele both among patients and among controls was 1.74%. None of the 119 patients studied upon diagnosis was a carrier of the mutation. Conclusion Our data suggested that the most common cause of iron overload is not associated with myocardial infarction. J Cardiovasc Risk 7: 37-40 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 14 条
  • [1] SERUM FERRITIN IS NOT A RISK FACTOR FOR CORONARY-ARTERY DISEASE IN MEN AND WOMEN AGED GREATER-THAN-OR-EQUAL-TO-62 YEARS
    ARONOW, WS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (03) : 347 - 348
  • [2] Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818
  • [3] ASCHERIO A, 1994, CIRCULATION, V89, P967
  • [4] Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
    Bulaj, ZJ
    Griffen, LM
    Jorde, LB
    Edwards, CQ
    Kushner, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) : 1799 - 1805
  • [5] A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
    Feder, JN
    Gnirke, A
    Thomas, W
    Tsuchihashi, Z
    Ruddy, DA
    Basava, A
    Dormishian, F
    Domingo, R
    Ellis, MC
    Fullan, A
    Hinton, LM
    Jones, NL
    Kimmel, BE
    Kronmal, GS
    Lauer, P
    Lee, VK
    Loeb, DB
    Mapa, FA
    McClelland, E
    Meyer, NC
    Mintier, GA
    Moeller, N
    Moore, T
    Morikang, E
    Prass, CE
    Quintana, L
    Starnes, SM
    Schatzman, RC
    Brunke, KJ
    Drayna, DT
    Risch, NJ
    Bacon, BR
    Wolff, RK
    [J]. NATURE GENETICS, 1996, 13 (04) : 399 - 408
  • [6] IRON STATUS AND CORONARY HEART-DISEASE - NEGATIVE FINDINGS FROM THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY
    LIAO, YL
    COOPER, RS
    MCGEE, DL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (07) : 704 - 712
  • [7] LOW IRON-BINDING-CAPACITY AS A RISK FACTOR FOR MYOCARDIAL-INFARCTION
    MAGNUSSON, MK
    SIGFUSSON, N
    SIGVALDASON, H
    JOHANNESSON, GM
    MAGNUSSON, S
    THORGEIRSSON, G
    [J]. CIRCULATION, 1994, 89 (01) : 102 - 108
  • [8] Global prevalence of putative haemochromatosis mutations
    MerryweatherClarke, AT
    Pointon, JJ
    Shearman, JD
    Robson, KJH
    [J]. JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) : 275 - 278
  • [9] SERUM IRON AND RISK OF FATAL ACUTE MYOCARDIAL-INFARCTION
    MORRISON, HI
    SEMENCIW, RM
    MAO, Y
    WIGLE, DT
    [J]. EPIDEMIOLOGY, 1994, 5 (02) : 243 - 246
  • [10] Increased ferritin gene expression in atherosclerotic lesions
    Pang, JHS
    Jiang, MJ
    Chen, YL
    Wang, FW
    Wang, DL
    Chu, SH
    Chau, LY
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) : 2204 - 2212